To view the PDF file, sign up for a MySharenet subscription.

STENPROP LIMITED - Unaudited condensed consolidated financial results for the nine months ended 31 December 2015

Release Date: 10/03/2016 08:00
Code(s): STP     PDF:  
Wrap Text
Unaudited condensed consolidated financial results for the nine months ended 31 December 2015

STENPROP LIMITED 
(Incorporated in Bermuda)
(Registration number 47031)
BSX share code: STP.BH JSE share code: STP ISIN: BMG8465Y1093
("Stenprop" or "the Company" or "the Group")

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL RESULTS for the nine months ended 31 December 2015

Stenprop Limited, a Bermuda company which has dual primary listings on the Bermuda Stock Exchange ("BSX") and the
Johannesburg Stock Exchange ("JSE"), today announces its results for the nine months ended 31 December 2015.
The company is required to publish financial results for the nine months ended 31 December 2015 in terms of the rules of the
BSX. Accordingly, this announcement presents the unaudited condensed consolidated financial results of the Group in respect
of the financial period from 1 April 2015 to 31 December 2015 in a form compliant with the requirements of the BSX.

FINANCIAL REVIEW

Earnings
The basic earnings attributable to ordinary shareholders for the nine-month period to 31 December 2015 were EUR33.5 million
(2014 pro forma(1): EUR18.6 million). This equates to a diluted IFRS EPS of 12.06 cents (2014 pro forma: 7.46 cents). The headline
earnings were EUR22.3 million (2014 pro forma: EUR16.2 million) equating to a diluted headline EPS of 8.03 cents (2014 pro forma: 
6.52 cents).

In accordance with reporting standards widely adopted across the real estate industry in Europe, the board of directors feels it is
appropriate and useful, in addition to providing the IFRS disclosed earnings, to also disclose EPRA(2) earnings.

Adjusted EPRA earnings attributable to shareholders for the nine-month period were EUR21.8 million (2014 pro forma: EUR18.3 million),
equating to a diluted adjusted EPRA EPS of 7.86 cents (2014 pro forma: 7.34 cents).

Net assets
The basic and diluted IFRS NAV per share at 31 December 2015 was EUR1.61 (2014: EUR1.45). The basic and diluted EPRA NAV per share
was EUR1.66 (2014: EUR1.50).

(1) The basis of preparation of the comparative pro forma is explained in note 1 to the financial statements
(2) European Public Real Estate Association

ACQUISITIONS DURING THE QUARTER

As previously reported, the purchase of the Victoria shopping centre for EUR20.6 million completed on 24 November 2015.
The property is located in the Lichtenberg district of Berlin, approximately 15 minutes by underground from the city centre
and is anchored by Kaufland (a hypermarket chain) on a new 17-year lease. The return on equity on this investment exceeded 8%
per annum at inception.

DIVIDENDS

On 26 November 2015, the Company announced an interim dividend of 4.2 cents per share in respect of the six months to
30 September 2015. On 25 January 2016, the Company announced a 41.5% take up of the scrip dividend for which 3,253,857 new
Stenprop shares were issued at an issue price of EUR1.49854 per share.

PROSPECTS

As announced on SENS in the Forecast Financial Information announcement published on 14 August 2015, the Group expected
adjusted diluted EPRA earnings per share for the year ended 31 March 2016 of 10.32 cents per share. Whilst fluctuations in
exchange rates used in our forecast may impact earnings, we remain on track to achieve our forecast.

Stenprop expects to declare a final dividend in June 2016 of 4.3 cents per share which, together with the interim dividend of
4.2 cents per share, will give a total dividend relating to the current financial year of 8.5 cents per share.

This general forecast has been based on the Group's own forecasts and has not been reported on by the external auditors.

CONDENSED CONSOLIDATED
STATEMENT OF COMPREHENSIVE INCOME
                                                                                                                     *Pro forma
                                                                                   Unaudited        Unaudited         Unaudited
                                                                                     for the          for the           for the
                                                                                 nine months      nine months       nine months
                                                                                       ended            ended             ended
                                                                                 31 December      31 December       31 December
                                                                                        2015             2014              2014
                                                                       Notes         EUR'000          EUR'000           EUR'000

Net rental income                                                                     29,523           10,624            25,298
Management fee income                                                                  2,057              823               890
Operating costs                                                                      (6,811)          (3,106)           (5,300)

Net operating income                                                                  24,769            8,341            20,888
Fair value movement of investment properties                                          10,249            4,970            16,162
Reversal of provision for selling costs                                                    –                –             5,612
Investment in associates                                                                 137              643             1,803
Investment in joint ventures                                                           7,530              442             1,551
Impairment of notional goodwill                                                            –                –          (19,374)

Profit from operations                                                                42,685           14,396            26,642
Gain on acquisition                                                                        –            9,657                 –
Other gains and losses                                                                     –               12                42
Net gain/(loss) from fair value of financial liabilities                               1,231            (128)                86
Net finance costs                                                                    (8,418)          (2,709)           (7,481)
Net foreign exchange gain/(loss)                                                           2             (52)              (36)

Profit for the period before taxation                                                 35,500           21,176            19,253
Taxation                                                                             (1,784)             (16)             (633)

Profit for the period after taxation                                                  33,716           21,160            18,620

Profit attributable to:
Equity holders                                                                        33,506           21,124            18,584
Non-controlling interest                                                                 210               36                36

Other comprehensive income
Items that may be reclassified subsequently to profit or loss:
Fair value movement on interest rate swaps                                               519             (48)              (48)
Foreign currency translation reserve                                                 (4,253)              232             2,773

Total comprehensive profit for the period                                             29,982           21,344            21,345

Total comprehensive profit attributable to:
Equity holders                                                                        29,772           21,344            21,309
Non-controlling interest                                                                 210               36                36

Earnings per share
IFRS EPS                                                     (cents)      2            12.09             8.49              7.47
Diluted IFRS EPS                                             (cents)      2            12.06             8.48              7.46
EPRA EPS                                                     (cents)      2             7.33             2.44              6.58
Diluted EPRA EPS                                             (cents)      2             7.31             2.44              6.57
Adjusted EPRA EPS                                            (cents)      2             7.88             2.70              7.35
Diluted adjusted EPRA EPS                                    (cents)      2             7.86             2.70              7.34

* Readers are referred to note 1 where the basis of preparation of the pro forma information is explained.

Results derive from continuing operations

CONDENSED CONSOLIDATED
STATEMENT OF FINANCIAL POSITION
                                                                                   Unaudited        Unaudited           Audited
                                                                                       as at            as at             as at
                                                                                 31 December      31 December          31 March
                                                                                        2015             2014              2015
                                                                      Notes          EUR'000          EUR'000           EUR'000
ASSETS
Investment properties                                                                748,159          558,341           695,196
Investment in associates                                                              39,235           35,193            39,652
Investment in joint ventures                                                          40,545            9,390             8,506
Investments                                                                                –              332                 –
Other debtors                                                                          7,449                –                 –
Property, plant and equipment                                                              3                5                 2
Total non-current assets                                                             835,391          603,261           743,356
Cash and cash equivalents                                                             37,367           46,068            80,430
Accounts receivable                                                                    3,369            1,553             2,634
Other debtors                                                                            617            1,588             3,910
Prepayments                                                                            1,994              873             1,519
Assets held for sale                                                                       –           60,918                 –
Total current assets                                                                  43,347          111,000            88,493
Total assets                                                                         878,738          714,261           831,849
Equity and liabilities
Capital and reserves
Share capital                                                            4                 –                –                 –
Share premium                                                            4           385,036          339,825           374,127
Equity reserve                                                                           303                –                 –
Retained earnings                                                                     47,665           21,087            37,561
Foreign currency translation reserve                                                  17,890              325            22,143
Cash flow hedge reserve                                                                    –            (136)             (519)
Total equity attributable to equity shareholders                                     450,894          361,101           433,312
Non-controlling interest                                                               2,025            1,758             1,815
Total equity                                                                         452,919          362,859           435,127
Non-current liabilities
Bank loans                                                                           272,609          283,316           296,873
Derivative financial instruments                                                       3,448            4,732             5,108
Other loan and interest                                                                   30              369                23
Deferred tax                                                                           8,429            6,075             7,230
Total non-current liabilities                                                        284,516          294,492           309,234
Current liabilities
Bank loans                                                                           109,582           24,993            68,058
Derivative financial instruments                                                         562                –             1,273
Accounts payable and accruals                                                         31,159           14,161            18,157
Liabilities directly associated with assets classified as held for sale                    –           17,756                 –
Total current liabilities                                                            141,303           56,910            87,488
Total liabilities                                                                    425,819          351,402           396,722
Total equity and liabilities                                                         878,738          714,261           831,849
IFRS net asset value per share                                           3              1.61             1.45              1.59
EPRA net asset value per share                                           3              1.66             1.50              1.65

CONDENSED CONSOLIDATED
STATEMENT OF CHANGES IN EQUITY
                                                                                                Attri-
                                                                       Foreign        Cash     butable
                                                                      currency        flow   to equity         Non-
                            Share     Share     Equity   Retained  translation       hedge      share-  controlling       Total
                          capital   premium    reserve   earnings      reserve     reserve     holders     interest      equity
                          EUR'000   EUR'000    EUR'000    EUR'000      EUR'000     EUR'000     EUR'000      EUR'000     EUR'000

Balance at 1 April 2015         –   374,127          –     37,561       22,143       (519)     433,312        1,815     435,127
Issue of share capital          –    10,909       (25)          –            –                  10,884            –      10,884
Credit to equity for
equity-settled share-
based payments                  –         –        328          –            –                     328            –         328
Total comprehensive
profit/(loss) for the
period                          –         –          –     33,506      (4,253)         519      29,772          210      29,982
Ordinary dividends              –         –          –   (23,402)                             (23,402)            –    (23,402)

Balance at
31 December 2015                –   385,036        303     47,665       17,890           –     450,894        2,025     452,919

Balance at 1 April 2014         –    21,131          –       (37)            –           5      21,099            –      21,099
Issue of share capital          –   320,854          –          –            –           –     320,854            –     320,854
Listing costs                   –   (2,160)          –          –            –           –     (2,160)            –     (2,160)
Novation of
swap contract                   –         –          –          –           93        (93)           –            –           –
Total comprehensive
profit/(loss) for the
period                                    –          –     21,124          232        (48)      21,308           36      21,344
Adjustments arising
from change in non-
controlling interest            –         –          –          –            –           –           –        1,722       1,722

Balance at
31 December 2014                –   339,825          –     21,087          325       (136)     361,101        1,758     362,859


CONDENSED CONSOLIDATED
STATEMENT OF CASH FLOWS
                                                                                                    Unaudited         Unaudited
                                                                                                      for the           for the
                                                                                                  nine months       nine months
                                                                                                        ended             ended
                                                                                                  31 December       31 December
                                                                                                         2015              2014
                                                                                                      EUR'000           EUR'000
Operating activities
Profit from operations                                                                                 42,685            14,396
Share of loss in associates                                                                             (137)             (643)
Increase in fair value of investment property                                                        (10,249)           (4,970)
Increase in fair value of joint venture                                                               (7,530)             (442)
Exchange rate gains/(losses)                                                                                2              (52)
Decrease/(increase) in trade and other receivables                                                        371           (1,313)
(Decrease)/increase in trade and other payables                                                         (102)               641
Interest paid                                                                                         (8,040)           (2,500)
Interest received                                                                                         768                 8
Net tax paid                                                                                            (342)             (260)

Net cash from operating activities                                                                     17,426             4,865

Investing activities
Dividends received from trading activities                                                                  –                 3
Dividends received from associates                                                                      1,388               562
Dividends received from joint ventures                                                                    315                 –
Purchase of investment properties                                                                    (45,797)                 –
Capital expenditure on investment properties                                                          (2,790)             (783)
Acquisition of investment in joint venture                                                           (26,782)                 –
Cash obtained on acquistion of subsidiaries                                                                 –            42,256

Net cash (used in)/from investing activities                                                         (73,666)            42,038

Financing activities
Repayment of borrowings                                                                              (37,796)           (2,046)
Dividends paid                                                                                        (8,198)                 –
Listing costs paid                                                                                          –             (989)
Financing fees paid                                                                                   (1,090)               (6)
Unutilised facility fee paid                                                                                –              (43)
Payments made on swap break                                                                             (571)                 –
New bank loans raised                                                                                  60,369                 –
New other loans                                                                                             –               346

Net cash from/(used in) financing activities                                                           12,714           (2,738)

Net (decrease)/increase in cash and cash equivalents                                                 (43,526)            44,165
Effect of foreign exchange rate changes                                                                   463               232
Cash and cash equivalents at beginning of the period                                                   80,430             1,671

Cash and cash equivalents at end of the period                                                         37,367            46,068

NOTES TO THE CONDENSED CONSOLIDATED
FINANCIAL STATEMENTS

1. BASIS OF PREPARATION

   These unaudited condensed consolidated financial results (the "IFRS Statements") for the nine months ended
   31 December 2015 have been prepared in accordance with the recognition and measurements principles of the
   International Financial Reporting Standards ("IFRS") and its interpretations adopted by the International Accounting
   Standards Board ("IASB"), and the listings requirements of the Bermuda Stock Exchange and the Johannesburg Stock
   Exchange as applicable.

   The accounting policies and methods of computation are consistent with those applied in the preparation of the annual
   financial statements for the year ended 31 March 2015 which were audited and reported on by the Group's external
   auditors, except for the new standards adopted during the period.

   These financial results have not been audited or reviewed by the Company's external auditors. They have been prepared
   by, and are the responsibility of the directors of Stenprop.

   Comparative pro forma
   In the interests of consistency in those areas of reporting that are seen to be of most relevance to investors, and of 
   providing a meaningful basis of comparison for users of the financial information, the Group has presented for the comparative
   period an unaudited pro forma statement of comprehensive income for the nine months ended 31 December 2014.
   The comparative pro forma statement, which is denominated in EUR, is for illustration purposes only and may not fairly
   represent the Group's results of operations.

   The main difference between the comparative pro forma statement and the comparative IFRS statement is that the
   comparative pro forma statement of comprehensive income has been prepared as if completion of the acquisition of the
   property owning companies had taken place on 1 April 2014, which was the effective date on which risk and reward passed
   to Stenprop in the purchase of the various property companies, while the comparative IFRS statement use the completion
   date of the acquisition (date that control passes), being 2 October 2014, to account for these investments.

   The comparative pro forma statement of comprehensive income therefore separately shows trading profits, property
   revaluations and other adjustments for the nine months ended 31 December 2014. In addition, the comparative pro
   forma statement of comprehensive income discloses the notional goodwill arising on the purchase of the management
   companies, the gain arising on the purchase of the property companies (which under IFRS is treated as one linked
   transaction), and the recognition of the amount of the deferred consideration which is reasonably expected to become
   payable.

2. EARNINGS PER ORDINARY SHARE
   Reconciliation of profit for the period to adjusted EPRA earnings
                                                                                                                     *Pro forma
                                                                                   Unaudited         Unaudited        Unaudited
                                                                                     for the           for the          for the
                                                                                 nine months       nine months      nine months
                                                                                       ended             ended            ended
                                                                                 31 December       31 December      31 December
                                                                                        2015              2014             2014
                                                                                     EUR'000           EUR'000          EUR'000

   Earnings per IFRS income statement attributable to shareholders                    33,506            21,124           18,584
   Adjustments to calculate EPRA earnings, exclude:                                                                           –
   Changes in fair value of investment properties                                   (10,249)           (4,970)         (16,162)
   Reversal of provision for selling costs                                                 –                 –          (5,612)
   Reversal of gain on acquisition                                                         –           (9,657)                –
   Reversal of impairment of goodwill                                                      –                 –           19,374
   Changes in fair value of financial instruments                                    (1,231)               128             (86)
   Deferred tax in respect of EPRA adjustments                                         1,347             (468)              106
   Adjustments above in respect of joint ventures and associates:
   Changes in fair value                                                             (3,004)              (90)              207
   Deferred tax in respect of EPRA adjustments                                          (66)                13             (32)

   EPRA earnings attributable to shareholders                                         20,303             6,080           16,379

   Further adjustments to arrive at adjusted EPRA earnings
   Straight-line unwind of purchased swaps                                             1,536               636            1,909

   Adjusted EPRA earnings attributable to shareholders                                21,839             6,716           18,288

   Weighted average number of shares in issue                                    277,112,787       248,902,812      248,902,812
   Share-based payment award                                                         652,799           291,563          291,563

   Diluted weighted average number of shares in issue                            277,765,586       249,194,375      249,194,375

   Earnings per share
   IFRS EPS                                                 (cents)                    12.09              8.49             7.47
   Diluted IFRS EPS                                         (cents)                    12.06              8.48             7.46
   EPRA EPS                                                 (cents)                     7.33              2.44             6.58
   Diluted EPRA EPS                                         (cents)                     7.31              2.44             6.57
   Adjusted EPRA EPS                                        (cents)                     7.88              2.70             7.35
   Diluted adjusted EPRA EPS                                (cents)                     7.86              2.70             7.34

   Straight-line unwind of purchased swaps
   A further adjustment was made to the EPRA earnings attributable to shareholders and relates to the straight-line unwind
   of the value as at 1 April 2014 of the swap contracts in the property companies acquired. When the property companies
   were acquired by Stenprop with effect from 1 April 2014, it also acquired the bank loans and swap contracts which were in
   place within these property companies. As a result, Stenprop took over loans with higher swap interest rates than would
   have been the case had new loans and swaps been put in place at 1 April 2014. To compensate for this, the value of the
   swap breaks costs was calculated at 1 April 2014 and the purchase consideration for the property companies was reduced
   accordingly to reflect this liability.

  
   Reconciliation of profit for the period to headline earnings
                                                                                                                     *Pro forma
                                                                                   Unaudited         Unaudited        Unaudited
                                                                                     for the           for the          for the
                                                                                 nine months       nine months      nine months
                                                                                       ended             ended            ended
                                                                                 31 December       31 December      31 December
                                                                                        2015              2014             2014
                                                                                     EUR'000           EUR'000          EUR'000

   Earnings per IFRS income statement attributable to shareholders                    33,506            21,124           18,584
   Adjustments to calculate headline earnings, exclude:
   Changes in fair value of investment properties                                   (10,249)           (4,970)         (16,162)
   Reversal of provision for selling costs                                                 –                 –          (5,612)
   Reversal of gain on acquisition                                                         –           (9,657)                –
   Reversal of impairment of goodwill                                                      –                 –           19,374
   Changes in fair value of financial instruments                                        519              (48)             (48)
   Deferred tax in respect of headline earnings adjustments                            1,347             (468)              106
   Adjustments above in respect of joint ventures and associates
   Changes in value of investment properties                                         (2,431)                 –                –
   Deferred tax                                                                        (399)                 –                –

   Headline earnings attributable to shareholders                                     22,293             5,981           16,242

   Earnings per share
   Headline EPS                                             (cents)                     8.04              2.40             6.53
   Diluted headline EPS                                     (cents)                     8.03              2.40             6.52

   * Readers are referred to note 1 where the basis of preparation of the pro forma information is explained.

3. NET ASSET VALUE PER ORDINARY SHARE
   Net asset value per share
                                                                                   Unaudited         Unaudited          Audited
                                                                                       as at             as at            as at
                                                                                 31 December       31 December         31 March
                                                                                        2015              2014             2015
                                                                                     EUR'000           EUR'000          EUR'000

  Net assets attributable to equity shareholders                                     450,894           361,101          433,312
  Adjustments to arrive at EPRA net asset value:
  Derivative financial instruments                                                     4,010             4,732            6,381
  Deferred tax                                                                         8,429             6,075            7,230
  Adjustments above in respect of non-controlling interests                            2,291             2,559            2,504

  EPRA net assets attributable to shareholders                                       465,624           374,467          449,427

  Number of shares in issue                                                      279,720,942       248,902,812      272,236,146
  Share-based payment awards                                                         652,799           291,563          291,563

  Diluted number of shares in issue                                              280,373,741       249,194,375      272,527,709

  Net asset value per share
  IFRS net asset value per share                            (cents)                     1.61              1.45             1.59
  Diluted IFRS net asset value per share                    (cents)                     1.61              1.45             1.59
  EPRA net asset value per share                            (cents)                     1.66              1.50             1.65
  Diluted EPRA net asset value per share                    (cents)                     1.66              1.50             1.65

                                                                                   Unaudited         Unaudited          Audited
                                                                                       as at             as at            as at
                                                                                 31 December       31 December         31 March
                                                                                        2015              2014             2015
                                                                                         EUR               EUR              EUR
4. SHARE CAPITAL
   Authorised
   1,000,000,000 ordinary shares with a par value of EUR0.000001258 each               1,258             1,258            1,258

                                                                                   Unaudited         Unaudited          Audited
                                                                                     for the           for the              for
                                                                                 nine months       nine months         the year
                                                                                       ended             ended            ended
                                                                                 31 December       31 December         31 March
                                                                                        2015              2014             2015

   Issued share capital
   Opening balance                                                               272,236,146        15,986,003       15,986,003
   Issue of new shares                                                             7,484,796       232,916,809      256,250,143

   Closing number of shares issued                                               279,720,942       248,902,812      272,236,146

   Share capital
   Share premium                                          (EUR 000)                  387,895           341,985          376,985
   Less: Acquisition/transaction costs                    (EUR 000)                  (2,859)           (2,160)          (2,858)
 
   Total share premium                                    (EUR 000)                  385,036           339,825          374,127

   There were no changes made to the number of authorised shares of the Company during the period under review.
   Stenprop Limited has one class of share; all shares rank equally and are fully paid. With effect from 5 October 2015, the
   Johannesburg Stock Exchange ("JSE") approved the transfer of Stenprop's listing from the JSE's AltX to the JSE's Main Board.
   The transfer does not affect the Company's current listing on the Bermuda Stock Exchange ("BSX").

   The Company has 279,720,942 (March 2015: 272,236,146) ordinary shares in issue at the reporting date which are dual listed
   on the BSX and the JSE.

5. EVENTS AFTER THE REPORTING PERIOD

   On 26 November 2015, the Company announced an interim distribution of 4.2 cents per share in respect of the six months
   to 30 September 2015 and offered shareholders the option to receive in respect of all or a part of their Stenprop shareholding
   either a scrip dividend by way of an issue of new Stenprop shares (of the same class as existing shares) credited as fully paid up
   or a cash dividend. On 25 January 2016, the Company announced a 41.5% take up of the scrip dividend, for which 3,253,857
   new Stenprop shares have been issued at a price of EUR1.49854 per share, resulting in the number of shares in issue, at the date
   of this announcement, being 282,974,799.

There were no changes to the board of directors during the period.

Stenprop has dual primary listings on the BSX and the JSE.

Date: 10 March 2016

South African corporate advisor and JSE sponsor
Java Capital

BSX sponsor
Appleby Securities (Bermuda) Limited

www.stenprop.com
Date: 10/03/2016 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story